| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 81003 |
|
150 |
149 |
$0.00 |
| 84481 |
|
230 |
229 |
$0.00 |
| 82274 |
|
138 |
137 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
194 |
191 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
344 |
344 |
$0.00 |
| 84439 |
|
348 |
346 |
$0.00 |
| 86696 |
|
217 |
215 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
711 |
640 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
113 |
107 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
27 |
27 |
$0.00 |
| 84403 |
|
92 |
88 |
$0.00 |
| 80061 |
Lipid panel |
1,773 |
1,766 |
$0.00 |
| 86480 |
|
35 |
35 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
691 |
681 |
$0.00 |
| 86708 |
|
210 |
209 |
$0.00 |
| 84100 |
|
158 |
155 |
$0.00 |
| 80074 |
|
140 |
139 |
$0.00 |
| 83540 |
|
132 |
132 |
$0.00 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
180 |
178 |
$0.00 |
| 86038 |
|
26 |
26 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
130 |
129 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
142 |
135 |
$0.00 |
| T4541 |
Incontinence product, disposable underpad, large, each |
83 |
82 |
$0.00 |
| 86900 |
|
113 |
98 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
212 |
210 |
$0.00 |
| 82570 |
|
249 |
247 |
$0.00 |
| 83655 |
|
141 |
141 |
$0.00 |
| 99173 |
|
274 |
274 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
112 |
112 |
$0.00 |
| 84702 |
|
18 |
15 |
$0.00 |
| 82565 |
|
13 |
12 |
$0.00 |
| 90670 |
|
29 |
29 |
$0.00 |
| 92081 |
|
136 |
136 |
$0.00 |
| 85610 |
|
197 |
177 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,204 |
1,103 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
54 |
54 |
$0.00 |
| 87186 |
|
56 |
56 |
$0.00 |
| 90633 |
|
26 |
26 |
$0.00 |
| 86709 |
|
112 |
111 |
$0.00 |
| 81025 |
|
260 |
239 |
$0.00 |
| 81002 |
|
173 |
162 |
$0.00 |
| 92552 |
|
137 |
137 |
$0.00 |
| 99223 |
Prolong inpt eval add15 m |
12 |
12 |
$0.00 |
| 59425 |
|
17 |
12 |
$0.00 |
| 82172 |
|
29 |
29 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
77 |
77 |
$0.00 |
| 84550 |
|
20 |
20 |
$0.00 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
131 |
127 |
$0.00 |
| 84460 |
|
89 |
88 |
$0.00 |
| 99051 |
|
428 |
401 |
$0.00 |
| 90461 |
|
14 |
14 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
74 |
66 |
$0.00 |
| 83970 |
|
14 |
14 |
$0.00 |
| 87799 |
|
43 |
43 |
$0.00 |
| 82542 |
|
65 |
60 |
$0.00 |
| 72114 |
|
16 |
16 |
$0.00 |
| 85007 |
|
27 |
27 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
27 |
15 |
$0.00 |
| 82248 |
|
143 |
136 |
$0.00 |
| 82947 |
|
27 |
27 |
$0.00 |
| 80076 |
|
16 |
16 |
$0.00 |
| 99222 |
Initial hospital care, per day, moderate complexity |
15 |
15 |
$0.00 |
| 82627 |
|
38 |
38 |
$0.00 |
| 3078F |
|
13 |
12 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
16 |
$0.00 |
| 83525 |
|
17 |
17 |
$0.00 |
| 87512 |
|
16 |
16 |
$0.00 |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
13 |
13 |
$0.00 |
| 86850 |
|
120 |
100 |
$0.00 |
| 81001 |
|
1,029 |
981 |
$0.00 |
| 82607 |
|
179 |
179 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
197 |
183 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
121 |
116 |
$0.00 |
| 96127 |
|
290 |
285 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
511 |
508 |
$0.00 |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
131 |
128 |
$0.00 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
451 |
442 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,576 |
1,466 |
$0.00 |
| 83690 |
|
172 |
158 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,725 |
6,565 |
$0.00 |
| 85018 |
|
388 |
386 |
$0.00 |
| 82550 |
|
89 |
84 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,691 |
2,543 |
$0.00 |
| 82962 |
|
169 |
154 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,949 |
2,742 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
246 |
215 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
454 |
436 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,317 |
3,151 |
$0.00 |
| 86695 |
|
219 |
217 |
$0.00 |
| 86704 |
|
211 |
210 |
$0.00 |
| 86762 |
|
57 |
57 |
$0.00 |
| 86901 |
|
98 |
84 |
$0.00 |
| 97802 |
|
312 |
303 |
$0.00 |
| 80050 |
General health panel |
66 |
66 |
$0.00 |
| 82553 |
|
77 |
75 |
$0.00 |
| 99000 |
|
134 |
132 |
$0.00 |
| 86317 |
|
210 |
209 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
360 |
339 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,366 |
1,360 |
$0.00 |
| 85027 |
|
369 |
359 |
$0.00 |
| 86800 |
|
80 |
80 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
190 |
190 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,453 |
1,446 |
$0.00 |
| 87088 |
|
228 |
223 |
$0.00 |
| 87340 |
|
411 |
410 |
$0.00 |
| 83001 |
|
80 |
80 |
$0.00 |
| 81000 |
|
159 |
159 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
633 |
624 |
$0.00 |
| T4535 |
Disposable liner/shield/guard/pad/undergarment, for incontinence, each |
42 |
37 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
28 |
15 |
$0.00 |
| 84484 |
|
166 |
158 |
$0.00 |
| J3490 |
Unclassified drugs |
179 |
110 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
746 |
744 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
691 |
681 |
$0.00 |
| 86592 |
|
500 |
498 |
$0.00 |
| 80069 |
|
20 |
18 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
107 |
106 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
65 |
59 |
$0.00 |
| 87040 |
|
42 |
40 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
104 |
104 |
$0.00 |
| 92551 |
|
251 |
250 |
$0.00 |
| 87081 |
|
178 |
172 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
30 |
29 |
$0.00 |
| 86140 |
|
107 |
100 |
$0.00 |
| 83605 |
|
30 |
29 |
$0.00 |
| 84480 |
|
86 |
86 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
57 |
53 |
$0.00 |
| 86803 |
|
372 |
370 |
$0.00 |
| 84479 |
|
120 |
120 |
$0.00 |
| 84153 |
|
119 |
118 |
$0.00 |
| 90674 |
|
13 |
13 |
$0.00 |
| 82672 |
|
46 |
46 |
$0.00 |
| 93000 |
|
12 |
12 |
$0.00 |
| 83735 |
|
44 |
43 |
$0.00 |
| 87070 |
|
16 |
16 |
$0.00 |
| 86376 |
|
89 |
89 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
15 |
15 |
$0.00 |
| 82664 |
|
13 |
13 |
$0.00 |
| 83880 |
|
29 |
27 |
$0.00 |
| 82670 |
|
67 |
67 |
$0.00 |
| 83704 |
|
68 |
68 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
51 |
51 |
$0.00 |
| 82043 |
|
198 |
198 |
$0.00 |
| 85652 |
|
82 |
79 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
216 |
182 |
$0.00 |
| 85730 |
|
50 |
47 |
$0.00 |
| 97010 |
|
25 |
12 |
$0.00 |
| 87077 |
|
27 |
27 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
54 |
54 |
$0.00 |
| 94760 |
|
187 |
85 |
$0.00 |
| 3008F |
|
340 |
305 |
$0.00 |
| 83789 |
|
64 |
60 |
$0.00 |
| 82746 |
|
59 |
59 |
$0.00 |
| 83002 |
|
31 |
31 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
14 |
$0.00 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
28 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
60 |
56 |
$0.00 |
| 82728 |
|
33 |
33 |
$0.00 |
| 84436 |
|
23 |
23 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
40 |
40 |
$0.00 |
| 82950 |
|
12 |
12 |
$0.00 |
| 99385 |
|
15 |
15 |
$0.00 |
| 84144 |
|
16 |
16 |
$0.00 |
| 90686 |
|
28 |
28 |
$0.00 |
| 83550 |
|
27 |
27 |
$0.00 |
| 87147 |
|
12 |
12 |
$0.00 |
| 99444 |
|
12 |
12 |
$0.00 |